Skip to content
Screener

Collegium Pharmaceutical, Inc. COLL Segment — Technical operations expenses

Similar metrics at other companies

ABM Industries logo
ABMTechnical Solutions — Other segment expense
$91.7M+26.8%
Centrus Energy logo
LEUTechnical Solutions Segment — Revenue
$83.5M+14.2%
SelectQuote logo
SLQTSenior Segment — Technical development
$0—
Willis Lease Finance logo
WLFCLeasing and  Related Operations — Technical expense
$9.73M+56.0%
Hycroft Mining Holding Corporation logo
HYMCReportable Segment — Technical and projects
$702K+87.7%
Centrus Energy logo
LEUTechnical Solutions Segment — Gross Profit
$3.6M+112%

Other financials

Income statement

See full
Revenue$199.9M+6.3%
Gross profit$110.3M+1.8%
Operating income$3.7M-89.5%
Net income-$15.1M-226%
EPS (diluted)-$0.46-235%

Balance sheet

See full
Cash & equivalents$150.4M+8.8%
Total debt$5.0M-19.8%
Total equity$311.9M+34.3%
Total assets$2.1B+34.1%

Cash flow

See full
Operating cash flow$71.3M-1.5%
CapEx$496.0K+663%
Free cash flow$70.8M-2.1%

Valuation

See full
Market cap$955.82M-16.0%
Enterprise value$810.41M-19.5%
P/E20×-11.4×
P/S1.2×-0.4×

Profitability

See full
Gross margin60%+3.3pp
Operating margin19.5%+1.1pp
Net margin5.9%+0.8pp
FCF margin40.6%+10.8pp

Returns & leverage

See full
Return on equity17.6%+1.4pp
Debt / equity0×0.0×
Current ratio1×-0.2×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept coll:TechnicalOperationsExpenses.

The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 7:34 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053851
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Commercial expenses46,40344,11593,76084,908
Corporate expenses12,1639,80126,70323,090
Medical expenses7,8997,83215,04715,865
Technical operations expenses165136415234
Stock-based compensation expense14,48410,81825,36422,342
Other segment items(1)25,48057731,6552,477
Interest expense19,51920,46335,38141,253
Interest income(2,289)(2,383)(5,995)(4,608)

Item 1. Condensed Consolidated Financial Statements (Unaudited).

FAQ

What is Collegium Pharmaceutical, Inc.'s segment — technical operations expenses?
Collegium Pharmaceutical, Inc. (COLL) reported segment — technical operations expenses of $165K in Q2 2026.
How has Collegium Pharmaceutical, Inc.'s segment — technical operations expenses changed year-over-year?
Collegium Pharmaceutical, Inc.'s segment — technical operations expenses increased by 21.3% year-over-year, from $136K to $165K.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s segment — technical operations expenses?
Over 3 years (2022 to 2025), Collegium Pharmaceutical, Inc.'s segment — technical operations expenses has grown at a -38.5% compound annual growth rate (CAGR), from $2.26M to $526K.
What does segment — technical operations expenses mean?
Covers costs related to supply chain management, quality control, and technical support for manufacturing processes. This metric reflects the operational investment required to ensure consistent product supply and quality standards.

Ask your AI about Collegium Pharmaceutical, Inc.'s segment — technical operations expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude